MGIC Investment Q2 Adjusted Earnings, Revenue Rise-March 2024-www.financetom.com

MGIC Investment Q2 Adjusted Earnings, Revenue Rise

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

MGIC Investment Q2 Adjusted Earnings, Revenue Rise

Aug 1, 2024 12:44 AM

03:21 AM EDT, 08/01/2024 (MT Newswires) -- MGIC Investment ( MTG ) reported late Wednesday Q2 adjusted net operating income of $0.77 per diluted share, up from $0.68 a year earlier.

Analysts polled by Capital IQ expected $0.63.

Revenue for the quarter ended June 30 was $305.3 million, up from $290.7 million a year earlier.

Analysts polled by Capital IQ expected $301 million.

Price: 24.51, Change: -0.33, Percent Change: -1.33

Previous page： Caledonia Mining Closes $150 Million Convertible Note Offering Next page： Amylyx Pharmaceuticals Insider Sold Shares Worth $1,877,570, According to a Recent SEC Filing

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Caledonia Mining Closes $150 Million Convertible Note Offering

Mar 11, 2026

03:34 AM EST, 01/21/2026 (MT Newswires) -- Caledonia Mining ( CMCL ) said late Tuesday it closed an upsized offering of 5.875% convertible senior notes due 2033 for a total amount of $150 million. The final figure included a full exercise of a $25 million option by initial purchasers to acquire additional notes, the company said. The notes carry an...

Amylyx Pharmaceuticals Insider Sold Shares Worth $1,877,570, According to a Recent SEC Filing

Mar 11, 2026

03:28 AM EST, 01/21/2026 (MT Newswires) -- Justin B. Klee, Director, Co-Chief Executive Officer, on January 15, 2026, sold 138,188 shares in Amylyx Pharmaceuticals ( AMLX ) for $1,877,570. Following the Form 4 filing with the SEC, Klee has control over a total of 3,379,398 common shares of the company, with 3,379,398 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1658551/000119312526017056/xslF345X05/ownership.xml ...

Amylyx Pharmaceuticals Insider Sold Shares Worth $1,878,094, According to a Recent SEC Filing

Mar 11, 2026

03:29 AM EST, 01/21/2026 (MT Newswires) -- Joshua B Cohen, Director, Co-Chief Executive Officer, on January 15, 2026, sold 138,167 shares in Amylyx Pharmaceuticals ( AMLX ) for $1,878,094. Following the Form 4 filing with the SEC, Cohen has control over a total of 3,379,465 common shares of the company, with 3,379,465 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1658551/000119312526017057/xslF345X05/ownership.xml ...

USA Rare Earth Stock Jumps On Expansion: Rare Earths, Real Gains

Mar 11, 2026

USA Rare Earth, Inc. ( USAR ) shares are moving higher on Tuesday after the company announced a strategic expansion into the European market. Through its subsidiary, Less Common Metals (LCM), USAR plans to develop a high-capacity metal and alloy production plant in Lacq, France, capable of producing 3,750 metric tons per annum. USAR stock is climbing. See the chart...